
2336 articles by Nick Paul Taylor
-
BD plans split from life science business to fuel medtech investment
Feb. 7, 2025 -
AHA joins call for Trump to exempt devices from import tariffs
Feb. 6, 2025 -
Pulse Biosciences names new CFO, continuing string of C-suite changes
Feb. 5, 2025 -
Medtronic recall of brain fluid drainage systems linked to 15 injuries
Feb. 4, 2025 -
GE Healthcare invests $138M to expand contrast media production at Ireland site
Feb. 4, 2025 -
FDA warns about patient monitor cybersecurity vulnerabilities
Jan. 31, 2025 -
23andMe considers sale as cash runs low
Jan. 30, 2025 -
Getinge exits surgical perfusion, creating opportunity for Livanova
Jan. 30, 2025 -
Neko Health raises $260M to expand body scan service, fund R&D
Jan. 28, 2025 -
Beta Bionics targets $114M IPO raise to fund insulin pump development
Jan. 27, 2025 -
Medtronic links closed-loop pain device to improvements after 12 months
Jan. 24, 2025 -
Intuitive inks deals to sell robots in Italy, Spain and Portugal
Jan. 23, 2025 -
Tarver warns that US device supply chain vulnerabilities could harm patients
Jan. 17, 2025 -
EU mulls retaliation after showing China’s bias against foreign device firms
Jan. 16, 2025 -
Boston Scientific ups PFA forecast, targets market leadership
Jan. 15, 2025 -
CMS starts Medicare coverage analysis for Medtronic, Recor renal denervation devices
Jan. 14, 2025 -
EU medtech regulations reducing options for patients, companies say
Jan. 13, 2025 -
Eko Health names Justin Spencer as CFO
Jan. 10, 2025 -
Fire1 raises $120M to trial heart failure management system
Jan. 10, 2025 -
Medtronic inks exclusive deal to sell Kuros bone graft device
Jan. 9, 2025 -
FDA finalizes guidance on device shortage reporting rules
Jan. 8, 2025 -
FDA posts early alert about safety risk of Medline’s fluid delivery sets
Jan. 6, 2025 -
FDA-commissioned review finds no safety concerns linked to tampons
Jan. 3, 2025 -
Top 10 medtech deals of 2024
Jan. 2, 2025 -
BD receives FDA warning letter over quality system violations
Dec. 20, 2024